Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Akebia Therapeutics, Inc. | 160,933 | reported | 10 Jun 2025 | tx 17+414,500−4,567 |
| Spero Therapeutics, Inc. | 75,000 | reported | 12 Jun 2025 | tx 9+110,848 |
| Protara Therapeutics, Inc. | 24,000 | reported | 12 Jun 2025 | tx 7+85,750 |
| AGIOS PHARMACEUTICALS, INC. | 12,414 | reported | 11 Aug 2025 | tx 18+112,091−12,414 |
| Tvardi Therapeutics, Inc. | 12,000 | reported | 17 Apr 2025 | tx 1+12,000 |
| ZS Pharma, Inc. | 0 | reported | 17 Dec 2015 | tx 13+62,067−282,919 |
| Dicerna Pharmaceuticals Inc | 0 | reported | 28 Dec 2021 | tx 14+89,999−89,999 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Aug 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,302 | 0.00 USD | |
| 11 Aug 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,302 | 0.00 USD | deriv |
| 20 Jun 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,120 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 2,816 | 0.00 USD | deriv |
| 20 Jun 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,120 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 15,768 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Spero Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 12 Jun 2025 | GRANT_AWARD | Protara Therapeutics, Inc. | 24,000 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 35,700 | 0.00 USD | |
| 10 Jun 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 53,600 | 0.00 USD | deriv |
| 17 Apr 2025 | GRANT_AWARD | Tvardi Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 11 Aug 2024 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,302 | 0.00 USD | |
| 11 Aug 2024 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,302 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 2,120 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 11,774 | 0.00 USD | deriv |
| 13 Jun 2024 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 3,388 | 0.00 USD | |
| 13 Jun 2024 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 3,388 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | Protara Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 30,000 | 0.00 USD | |
| 06 Jun 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Spero Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 05 Oct 2023 | GRANT_AWARD | Spero Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 11 Aug 2023 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,302 | 0.00 USD | |
| 11 Aug 2023 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,302 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 3,388 | 0.00 USD | deriv |